IQV - AbbVie's Humira outperforms forcing biosimilar maker to cut sales staff
2024-04-05 08:30:53 ET
More on AbbVie
- AbbVie Inc. (ABBV) Barclays 26th Annual Global Healthcare Conference (Transcript)
- AbbVie: Comeback Expected After Humira Patent Expiration
- AbbVie Stock: I Was So Wrong, But This Is Way Too Fast
- AbbVie slips after revising guidance to reflect earnings impact
- Aldeyra gains as Oppenheimer upgrades on revised plans for lead asset